Recent Posts
- HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
- HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
- HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
- MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
- Invizyne Technologies Begins Trading on NASDAQ
Recent Comments